Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

2017; American Society for Clinical Investigation; Volume: 2; Issue: 3 Linguagem: Inglês

10.1172/jci.insight.89798

ISSN

2379-3708

Autores

Matthew J. Hartwell, Umut Özbek, Ernst Holler, Anne S. Renteria, Hannah Major-Monfried, Pavan Reddy, Mina Aziz, William J. Hogan, Francis Ayuk, Yvonne A. Efebera, Elizabeth O. Hexner, Udomsak Bunworasate, Muna Qayed, Rainer Ordemann, Matthias Wölfl, Stephan Mielke, Attaphol Pawarode, Yi‐Bin Chen, Steven M. Devine, Andrew C. Harris, Madan Jagasia, Carrie L. Kitko, Mark R. Litzow, Nicolaus Kröger, Franco Locatelli, George Morales, Ryotaro Nakamura, Ran Reshef, Wolf Rösler, Daniela Weber, Kitsada Wudhikarn, Gregory A. Yanik, John E. Levine, James L.M. Ferrara,

Tópico(s)

Extracellular vesicles in disease

Resumo

BACKGROUND. No laboratory test can predict the risk of nonrelapse mortality (NRM) or severe graft-versus-host disease (GVHD) after hematopoietic cellular transplantation (HCT) prior to the onset of GVHD symptoms.

Referência(s)